Ally Bridge Group »

Korro Bio shares owned by Ally Bridge Group

Quarter-by-quarter ownership of Korro Bio (KRRO) shares owned by Ally Bridge Group from 13F filings

Historical chart of Ally Bridge Group investment in Korro Bio

Tip: Access up to 7 years of quarterly data

All positions including Korro Bio held by Ally Bridge Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Korro Bio by Ally Bridge Group

Quarter filed Position value Share count Share price at filing
2025-06-30 $1.9M 154k 12.49
2025-03-31 $1.0M 60k 17.41
2024-12-31 $2.7M 71k 38.07

More positions owned by Ally Bridge Group

Soleno Therapeutics (SLNO)
Replimune Group Call Option (REPL)
Madrigal Pharmaceuticals (MDGL)
Compass Pathways Sponsored Ads (CMPS)
Atai Beckley Nv SHS (ATAI)
Ascendis Pharma A/s - Sponsored Adr (ASND)
Lenz Therapeutics (LENZ)
Taysha Gene Therapies Com Shs (TSHA)
Amylyx Pharmaceuticals (AMLX)
Eupraxia Pharmaceuticals (EPRX)
Praxis Precision Medicines I Com New Call Option (PRAX)
Monopar Therapeutics Com New (MNPR)
Arcutis Biotherapeutics (ARQT)
Mind Medicine Mindmed Com New (MNMD)
Tarsus Pharmaceuticals (TARS)

View all positions for Ally Bridge Group

Top funds holding Korro Bio

Atlas Venture Life Science Advisors
NEA Management Company
Driehaus Capital Management
FMR
Point72 Asset Management
Cormorant Asset Management
BlackRock
Siren
TCG Crossover Management
Vanguard Group
Qiming U.S. Ventures Management
Tri Locum Partners
72 Investment Holdings
Polar Capital Holdings
Millennium Management

View all funds holding Korro Bio